ICAM1 and rheumatoid arthritis: Moreover, Dexamethasone-integrated MSC-based biomimetic liposomes enhance their affinity for polarized macrophages via the LFA-1/ICAM-1 interaction, thereby improving the therapeutic efficacy in rheumatoid arthritis (RA) [175].